Tissuevision Inc SBIR Phase I Award, September 2022

A SBIR Phase I contract was awarded to Tissuevision, Inc in September, 2022 for $353,769.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/2341101

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Tissuevision, Inc

Government Agency

Government Branch

National Institutes of Health

Award Type

SBIR0

Contract Number (US Government)

1R43EB033786-010

Award Phase

Phase I0

Award Amount (USD)

353,7690

Date Awarded

September 1, 2022

End Date

August 31, 2023

Abstract

Project Summary This proposal describes the development of unique fee-for-service histology analysis platform from TissueVision, Inc. It will allow researchers in academia and industry to easily acquire label-free 3D histological images with Second Harmonic Generation (SHG) and Third Harmonic Generation (THG) contrast. These images can be analyzed by TissueVision Incandapos;s custom image analysis algorithms to provide quantitative and powerful insights into areas such as cancer, dermatology, fibrosis, and heart disease.